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Abstract
Humans cannot live at very high altitude for reasons, which are not completely 
understood. Since these reasons are not restricted to cardiorespiratory changes alone, 
changes in the endocrine system might also be involved. Therefore, hormonal changes 
during prolonged hypobaric hypoxia were comprehensively assessed to determine 
effects of altitude and hypoxia on stress, thyroid and gonadal hypothalamus–pituitary 
hormone axes. Twenty-one male and 19 female participants were examined repetitively 
during a high-altitude expedition. Cortisol, prolactin, thyroid-stimulating hormone 
(TSH), fT4 and fT3 and in males follicle-stimulating hormone (FSH), luteinizing hormone 
(LH) and total testosterone were analysed as well as parameters of hypoxemia, 
such as SaO2 and paO2 at 550 m (baseline) (n = 40), during ascent at 4844 m (n = 38), 
6022 m (n = 31) and 7050 m (n = 13), at 4844 m (n = 29) after acclimatization and after 
the expedition (n = 38). Correlation analysis of hormone concentrations with oxygen 
parameters and with altitude revealed statistical association in most cases only with 
altitude. Adrenal, thyroid and gonadal axes were affected by increasing altitude. 
Adrenal axis and prolactin were first supressed at 4844 m and then activated with 
increasing altitude; thyroid and gonadal axes were directly activated or suppressed 
respectively with increasing altitude. Acclimatisation at 4844 m led to normalization of 
adrenal and gonadal but not of thyroid axes. In conclusion, acclimatization partly leads 
to a normalization of the adrenal, thyroid and gonadal axes at around 5000 m. However, 
at higher altitude, endocrine dysregulation is pronounced and might contribute to the 
physical degradation found at high altitude.
Introduction
Humans have populated a wide variety of climatic and 
geographical regions of the world. However, altitudes of 
around 5000 m are only permanently colonized in rare 
cases, for example mining communities in the Andes. 
This fact can be explained not only by the hostile climate, 
but also by the inadequate physiological capacity of the 
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human organism to adapt to this altitude in the long term 
or to reproduce in this environment.
A longer-term existence at high altitude requires 
a variety of cardiorespiratory and metabolic changes 
(Luks, 1985), a compensated metabolism and, in the case 
of permanent settlement at higher altitudes, adequate 
fertility.
This raises the question of whether the endocrine 
system, which plays a central role in the regulation 
of almost all bodily functions, becomes significantly 
dysregulated above a certain altitude.
Several studies have already investigated various 
hormone concentrations at high altitude (1, 2, 3, 4, 5, 6, 
7, 8, 9, 10).
However, the study groups were mostly small, limited 
to men, were only carried out at altitudes of up to 5000 m 
above sea level or the study design was not ideal. This 
might be the reason for the often heterogeneous results 
of these studies, which have not allowed a conclusive 
statement about the effect of altitude on the endocrine 
system to be made up to now.
The aim was therefore to perform an observational 
study in a large collective, with both male and female 
subjects at various altitudes up to 7000 m under 
standardized conditions and to investigate the changes in 
the adrenal, thyroid and gonadal hypothalamus–pituitary 
end-organ axes.
Materials and methods
Setting
This was a prospective observational cohort study 
conducted during the Swiss High Altitude Medical 
Research Expedition Himlung Himal 2013 (11). The aim of 
this project was to investigate the cerebral, cardiovascular, 
pulmonary and humoral adaptation to prolonged 
hypobaric hypoxia during an ascent to Mount Himlung 
Himal (7126 m) in Nepal.
Baseline and post expedition testing was performed in 
two groups in Berne, Switzerland (550 m) 8 and 9 weeks 
before the start of the expedition (PR = Pre expedition). For 
logistical reasons, the journey as well as the expedition 
testing were planned in two groups with identical 
ascent profiles. Comprehensive medical assessments 
were performed in Base Camp (BC1) at 4844 m on day 
7, in Camp 2 (C2) (6022 m) on day 13 and in Camp 3 
(C3) (7050 m) on day 23/24 respectively. An additional 
measurement was carried out at Base Camp on day 
19/20 (BC2) to study the effect of acclimatization. A final 
analysis was performed 4–5 weeks after the expedition at 
550 m (PO = Post-expedition).
The number of subjects included in this study 
was restricted due to logistical and safety concerns. 
Forty healthy subjects (21 male, 19 female), with basic 
mountaineering experience and aged between 18 and 
70  years, were included in the trial. Exclusion criteria 
consisted of the presence of any neurologic, cardiac or 
respiratory disease, diabetes mellitus type I or II or the 
need for any regular medication, particularly thyroid 
hormones, corticosteroids and other medication, which 
could possibly affect hormone analysis. In addition, 
subjects were excluded if a known susceptibility for high 
altitude sickness was present. Susceptibility was defined as 
a history of severe acute mountain sickness, high altitude 
cerebral oedema (HACE) or high altitude pulmonary 
oedema (HAPE) after a rapid ascent (<3 nights) at altitudes 
below 3500 m.
The study was approved by the Cantonal Ethics 
Committee (KEK 226/12) and has been registered on 
clinicaltrials.gov (NCT01953198). Consent has been 
obtained from each patient after full explanation of the 
purpose and nature of all procedures used.
Measurements
Arterial blood gas sampling and oxygen transport 
parameters: Arterial blood was aspirated using a blood 
gas sampler (safe PICO Aspirator, Radiometer Medical, 
Denmark) and immediate analysis was done with a pocket 
analyser (Epoc, Alere, Wadenswil, Switzerland) to assess 
arterial oxygen saturation (SaO2), partial pressure for O2 
(paO2) and haemoglobin (Hb).
Blood sampling: At each study site, fasting blood 
samples were taken between 07.15 and 09.00 h. The 
samples were collected in sterile serum tubes (Sarstedt, 
Sevelen, Switzerland). All samples were immediately 
centrifuged for 10 min at 2000 g (EBA 20, Hettich AG, 
Bäch, Switzerland). Aliquots were frozen to −40° to −60°C 
on-site and stored at −80°C thereafter.
Cortisol, prolactin, thyroid-stimulating hormone 
(TSH), free tetraiodothyronine (fT4), free triiodothyronine 
(fT3), follicle-stimulating hormone (FSH), luteinizing 
hormone (LH) and total testosterone (testosterone) were 
analysed. FSH, LH and testosterone were only evaluated 
in males due to the menstrual-dependent fluctuations in 
females.
Hormone analysis: Cortisol levels were determined 
using a competitive immunoassay based on a 
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chemiluminescence technology (Advia Centaur Cortisol 
Assay, Siemens) on an Advia Centaur System (Siemens). 
Reference values were 140–700 nmol/L. Quantitative 
assessment of prolactin (PRL) and LH levels was performed 
on Dimension Vista R System (Siemens) using a sandwich 
chemiluminescent immunoassay (Flex Reagent Cartridge, 
Siemens). The respective reference intervals for PRL 
were in adult females 2.2–28 µg/L and in adult males 
2.7–17 µg/L. The same method was used for the quantitative 
determination of TSH, fT3 and fT4. Reference values for 
fT3 were 3.2–6.2 pmol/L, for fT4 9.9–19.3 pmol/L and for 
TSH 0.4–4.0 mIU/L. Testosterone was assessed with a solid-
phase chemiluminescent immune assay (IMMULITE 2000 
System, Siemens). Respective reference ranges in men 
aged ≤60 years were 7–32 nmol/L and in men >60 years 
5–32 nmol/L.
FSH was measured using a homogeneous sandwich 
chemiluminescent immunoassay (FSH Flex Reagent 
Cartridge, Siemens) on a Dimension Vista System. 
Reference values in adult males are 0.7–11 IU/L.
Statistics
Clinical data are presented as mean and standard deviation 
(s.d.). Standard errors (s.e.) are also presented when CIs are 
given.
To assess the effects of altitude and hypoxia on a 
selected group of hormones, generalized estimating 
equation modelling was employed in order to efficiently 
accommodate the longitudinal measurements during 
the expedition. Sidak adjustment was used for multiple 
pairwise (post hoc) comparisons. P values less than 0.05 
were considered statistically significant. Adjustment 
for sex, SaO2 or CaO2 was performed where needed as 
assessed by initial univariate analyses. Data analysis was 
performed using STATA 13.1, (STATA Corp.).
Results
Of the 40 subjects, one met an exclusion criterion during 
the baseline testing and was therefore excluded from the 
following expedition. Number of subjects was lower at 
high altitudes but the average age of the analysed subjects 
was not different. SaO2, paO2 and Hb varied significantly 
at different altitudes (Table 1).
Hormone concentrations were assessed for the effect 
of hypoxia parameters and altitude. In most cases, only 
altitude resulted in a significant effect (Tables 2, 3, 4, 5, 
6, 7, 8, 9 and 10). Prolactin concentrations were also sex 
dependent (P = 0.015). fT3 (P = 0.024) and testosterone 
(P = 0.028) were SaO2 dependent and TSH (P = 0.011) was 
pO2 dependent. Accordingly, in the modelling approach, 
we adjusted for these parameters while assessing the effect 
of altitude. Average hormone concentrations stayed within 
the normal ranges at all altitudes; however, in individual 
cases concentrations reached pathological concentrations 
as shown in Figs 1 and 2 for cortisol and fT4.
Hormone axes were affected by altitude as follows:
Adrenal axis and prolactin
Cortisol concentrations revealed a U-shaped pattern with 
increasing altitude (Fig. 1 and Table 2). Concentrations first 
decreased significantly from 474 ± 163 nmol/L before the 
expedition (baseline) to 369 ± 106 at 4844 m and increased 
1.7-fold thereafter to reach 643 ± 91 nmol/L at 7050 m 
altitude. Acclimatization at 4844 m led to normalization 
of cortisol concentration compared to baseline. These 
changes were neither sex nor SaO2 or paO2 dependent.
Changes in prolactin (Table  3) concentrations were 
less pronounced. Prolactin also dropped significantly at 
4844 m and increased at 6022 m, but the increase was 
not significant. However, prolactin also normalized at 
4844 m after acclimatization as prolactin concentration 
Table 1 Basic characteristics of subjects.
PR BC1 C2 BC2 C3 PO P value
Subjects total, n 40 38 31 29 13 38
Females, n 19 17 14 13 5 17
Males, n 21 21 17 16 8 21
Age total (mean ± s.d.) 45.56 ± 12.06 46.08 ± 11.78 46.39 ± 12.36 47.18 ± 11.90 43.85 ± 13.74 45.37 ± 12.16 n.s.
Age females (mean ± s.d.) 40.94 ± 10.96 41.82 ± 10.62 42.00 ± 11.25 43.75 ± 10.23 37.20 ± 13.66 40.24 ± 10.86 n.s.
Age males (mean ± s.d.) 49.52 ± 11.78 49.52 ± 11.78 50.00 ± 12.37 49.75 ± 12.71 48.00 ± 12.87 49.52 ± 11.78 n.s.
SaO2 (mean ± s.d.) 97.57 ± 0.79 83.78 ± 4.59 72.71 ± 8.83 88.59 ± 2.34 68.8 ± 9.65 97.43 ± 0.69 <0.001
paO2 (mean ± s.d.) 95.35 ± 7.87 44.18 ± 4.52 34.34 ± 4.99 50.98 ± 3.57 30.38 ± 4.41 93.22 ± 7.22 <0.001
Hb (mean ± s.d.) 14.80 ± 0.93 15.35 ± 0.90 16.03 ± 1.10 17.03 ± 0.89 17.5 ± 1.00 15.21 ± 0.91 <0.001
Altitudes: PR, Pre expedition = 550 m; BC1, Base Camp 1 = 4.844 m; C2, Camp2 = 6022 m; BC2, Base Camp 2 (after acclimatization) = 4.844 m; C3, 
Camp3 = 7050 m; PO, Post expedition = 550 m.
SaO2, saturation arterial oxygen (%); paO2, partial pressure of oxygen (mmHg); Hb, haemoglobin (g/L).
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was not significantly different from baseline after the 
acclimatization period. Prolactin concentrations were sex 
but not SaO2 or paO2 dependent.
Thyroid axis
TSH (Table 4) concentrations were not different compared 
to baseline apart from 7050 m altitude at which TSH 
concentration were 1.7-fold higher. In contrast, fT4 
(Fig.  2 and Table  5) increased constantly with each 
altitude from 12.7 ± 1.5 pmol/L before the expedition to 
reach 16.1 pmol/L at 7050 m. During acclimatization at 
4844 m, fT4 concentration decreased but stayed higher 
than baseline. These changes were less pronounced for 
fT3 (Table 6). At 4844 m fT3 concentrations also increased 
significantly, but at 6022 m and 7050 m altitude fT3 
concentrations were similar to baseline. The thyroid axis 
was partly hypoxia dependent. TSH was paO2 and fT3 was 
SaO2 and paO2 dependent.
Gonadal axes
FSH (Table  7) decreased from 5.8 ± 5.9 mU/L before the 
expedition constantly with increasing altitude to reach 
3.3 ± 2.1 mU/L at 7050 m, which corresponds with a 
40% decrease. After acclimatization at 4844 m, FSH 
concentrations normalized compared to baseline.
LH concentrations (Table  8) also decreased 
significantly by around 50% between baseline and 7050 m 
altitude. However, the decrease could not be observed 
at all altitudes. At 6022 m, there was an even smaller 
increase compared to 4844 m. The normalizing effect 
of acclimatization could also be seen for LH. At 4844 m, 
LH concentrations were significantly lower compared to 
baseline, an effect that was not recognizable anymore 
after acclimatization.
Testosterone concentrations were similar at all 
altitudes apart from 7050 m altitude. At this altitude, 
testosterone concentration was – in parallel to reduced 
concentrations of LH at that altitude – 50% lower 
compared to baseline. A hypoxia dependency of the 
Table 2 Cortisol concentrations (nmol/L) at different altitude 
levels in the whole group of subjects and differences relative 
to PR.
Mean ± s.d. n
Differences relative to Pr
Coefficient ± s.e. P value 95% CI
PR 474 ± 163 33
BC1 369 ± 106 32 −110 ± 28 0.001 −165; −56
C2 564 ± 152 13 48 ± 38 0.211 −27; 123
BC2 537 ± 189 24 51 ± 30 0.096 −9; 111
C3 643 ± 91 7 161 ± 49 0.001 65; 257
PO 472 ± 180 34 −8 ± 27 0.757 −62; 45
Variation of cortisol concentrations were not sex, SaO2 or paO2 
dependent.
Altitudes: PR, Pre expedition = 550 m; BC1, Base Camp 1 = 4.844 m; C2, 
Camp2 = 6022 m; BC2, Base Camp 2 (after acclimatization) = 4.844 m; C3, 
Camp3 = 7050 m; PO, Post expedition = 550 m.
Table 3 Prolactin concentrations (µg/L) at different altitude 
levels in the whole group of subjects and differences relative 
to PR.
Mean ± s.d. N
Differences relative to Pr (adjusted for sex)
Coefficient ± s.e. P value 95% CI
PR 9.1 ± 4.1 33
BC1 6.9 ± 4.9 32 −2.2 ± 0.6 <0.001 −3.4; −0.9
C2 8.3 ± 5.9 13 −1.2 ± 0.8 0.143 −2.9; 0.4
BC2 7.1 ± 4.0 23 −1.5 ± 0.7 0.031 −2.8; −0.1
C3 5.4 ± 1.1 7 −2.4 ± 1.1 0.026 −4.5; −0.3
PO 8.5 ± 3.6 34 −0.5 ± 0.6 0.368 −1.7; 0.6
Variation of prolactin was sex (P = 0.015) but not SaO2 or paO2 dependent.
Altitudes: PR, Pre expedition = 550 m; BC1, Base Camp 1 = 4.844 m; C2, 
Camp2 = 6022 m; BC2, Base Camp 2 (after acclimatization) = 4.844 m; C3, 
Camp3 = 7050 m; PO, Post expedition = 550 m.
Table 4 TSH concentrations (mU/L) at different altitude 
levels in the whole group of subjects and differences relative 
to PR.
Mean ± s.d. N
Differences relative to Pr (adjusted for paO2)
Coefficient ± s.e. P value 95% CI
PR 2.15 ± 1.33 38
BC1 2.27 ± 1.22 38 0.07 ± 0.10 0.471 −0.13; 0.28
C2 2.20 ± 1.26 30 0.03 ± 0.11 0.770 −0.18; 0.25
C3 3.46 ± 2.88 13 1.08 ± 0.15 <0.001 0.79; 1.38
BC2 2.28 ± 1.43 27 0.08 ± 0.11 0.471 −0.14; 0.31
PO 1.93 ± 1.09 37 −0.20 ± 0.10 0.055 −0.40; 0.01
Variation of TSH was not sex and SaO2 but PaO2 (P = 0.011) dependent.
Altitudes: PR, Pre expedition = 550 m; BC1, Base Camp 1 = 4.844 m; C2, 
Camp2 = 6022 m; BC2, Base Camp 2 (after acclimatization) = 4.844 m; C3, 
Camp3 = 7050 m; PO, Post expedition = 550 m.
Table 5 fT4 concentrations (pmol/L) at different altitude 
levels in the whole group of subjects and differences relative 
to PR.
Mean ± s.d. N
Differences relative to Pr
Coefficient ± s.e. P value 95% CI
PR 12.7 ± 1.5 39
BC1 15.2 ± 2.2 38 2.5 ± 0.3 <0.001 2.0; 3.0
C2 15.4 ± 2.3 31 2.7 ± 0.3 <0.001 2.2; 3.3
C3 16.1 ± 2.1 13 3.9 ± 0.4 <0.001 3.1; 4.6
BC2 14.1 ± .2.1 28 1.5 ± 0.3 <0.001 1.0; 2.1
PO 12.3 ± 1.5 38 −0.4 ± 0.3 0.1.76 −0.9; 1.2
Variation of fT4 was not sex, SaO2 or paO2 dependent.
Altitudes: PR, Pre expedition = 550 m; BC1, Base Camp 1 = 4.844 m; C2, 
Camp2 = 6022 m; BC2, Base Camp 2 (after acclimatization) = 4.844 m; C3, 
Camp3 = 7050 m; PO, Post expedition = 550 m.
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gonadal endocrine parameters could only be found for 
testosterone, which was SaO2 dependent.
In summary, adrenal, thyroid and gonadal axes as well 
as prolactin secretion were affected by increasing altitude. 
Adrenal axis and prolactin were first suppressed at 4844 m 
and then activated with increasing altitude; thyroid axis 
and gonadal axis were both directly activated respectively 
suppressed with increasing altitude. Acclimatisation at 
4844 m led to normalization of adrenal and gonadal but 
not of thyroid axes.
Discussion
Our study revealed that adrenal and thyroid axes as well 
as prolactin secretion are activated, and male gonadal axis 
is suppressed at high altitude. The study also revealed that 
acclimatization at 4844 m led to normalization of adrenal 
and gonadal but not of thyroid axes.
Previous studies have already analysed endocrine 
parameters at different altitudes but revealed heterogeneous 
or even controversial results, which might be due to the 
small study sizes or suboptimal study designs.
As we performed a study with a large study group 
with both male and female participants, with an 
analysis at various altitude levels up to 7050 m and 
under study conditions, which were standardized as 
much as possible, we assume that our study results are 
quite representative. However, our study design could 
not exclude all confounders, which a field study is 
confronted with. We therefore tried to include several 
hormone parameters for each analysed hormone axis 
to get a more representative and more comprehensive 
picture of the endocrine system.
The reason for our study was not only to better 
understand what kind of metabolic changes and 
adaptations mountaineers face at high altitude 
expeditions, we also hoped to understand if the endocrine 
systems contribute to the incapability of humans to live 
above around 5000 m altitude.
Table 6 fT3 concentrations (pmol/L) at different altitude 
levels in the whole group of subjects and differences relative 
to PR.
Mean ± s.d. n
Differences relative to Pr (adjusted for SaO2)
Coefficient ± s.e. P value 95% CI
PR 4.57 ± 0.60 39
BC1 5.26 ± 0.73 38 0.69 ± 0.10 <0.001 0.50; 0.89
C2 4.56 ± 0.74 31 0.02 ± 0.10 0.855 −0.19; 0.22
C3 4.76 ± 0.76 13 0.21 ± 0.14 0.143 −0.07; 0.49
BC2 4.74 ± 0.56 29 0.15 ± 0.11 0.169 −0.62; 0.36
PO 4.89 ± 0.61 38 0.28 ± 0.10 0.004 0.10; 0.47
Variation of fT3 was not sex but SaO2 (P = 0.018) and paO2 (P = 0.024) 
dependent.
Altitudes: PR, Pre expedition = 550 m; BC1, Base Camp 1 = 4.844 m; C2, 
Camp2 = 6022 m; BC2, Base Camp 2 (after acclimatization) = 4.844 m; C3, 
Camp3 = 7050 m; PO, Post expedition = 550 m.
Table 7 FSH concentrations (mU/L) at different altitude 
levels in the whole group of subjects and differences relative 
to PR.
Mean ± s.d. n
Differences relative to Pr
Coefficient ± s.e. P value 95% CI
PR 5.81 ± 5.95 21
BC1 4.77 ± 5.64 21 −1.10 ± 0.44 0.011 −1.96; −0.25
C2 4.33 ± 4.46 17 −2.10 ± 4.69 <0.001 −0.30; −1.19
C3 3.38 ± 2.10 8 −1.66 ± 0.62 0.007 −2.87; −0.45
BC2 6.00 ± 6.58 16 −0.66 ± 0.48 0.167 −1.59; 0.27
PO 6.03 ± 5.89 21 0.16 ± 4.37 0.712 −0.69; 1.01
Variation of FSH was not sex, SaO2 or paO2 dependent.
Altitudes: PR, Pre expedition = 550 m; BC1, Base Camp 1 = 4.844 m; C2, 
Camp2 = 6022 m; BC2, Base Camp 2 (after acclimatization) = 4.844 m; C3, 
Camp3 = 7050 m; PO, Post expedition = 550 m.
Table 8 LH concentrations (mU/L) at different altitude levels 
in the whole group of subjects and differences relative to PR.
Mean ± s.d. n
Differences relative to Pr
Coefficient ± s.e. P value 95% CI
PR 3.81 ± 1.98 18
BC1 2.39 ± 1.55 19 −1.57 ± 0.36 <0.001 −0.29; −0.85
C2 3.00 ± 1.52 18 −1.45 ± 0.49 0.003 −2.41; −0.48
C3 1.88 ± 1.25 6 −1.85 ± 0.54 0.001 −2.91; −0.79
BC2 3.26 ± 1.87 14 0.79 ± 0.39 0.044 −1.57; −0.21
PO 3.60 ± 1.59 19 −0.34 ± 0.37 0.346 −1.04; 0.37
Variation of LH was not sex, SaO2 and paO2 dependent.
Altitudes: PR, Pre expedition = 550 m; BC1, Base Camp 1 = 4.844 m; C2, 
Camp2 = 6022 m; BC2, Base Camp 2 (after acclimatization) = 4.844 m; C3, 
Camp3 = 7050 m; PO, Post expedition = 550 m.
Table 9 Testosterone concentrations (nmol/L) at different 
altitude levels in the whole group of subjects and differences 
relative to PR.
Mean ± s.d. n
Differences relative to Pr (adjusted for SaO2)
Coefficient ± s.e. P value 95% CI
PR 21.5 ± 10.1 18
BC1 21.1 ± 13.6 19 −0.5 ± 2.5 0.821 −5.6; 4.4
C2 23.9 ± 13.5 8 1.8 ± 3.4 0.585 −4.8; 8.6
C3 10.7 ± 3.2 6 −10.7 ± 3.7 0.007 −18.1; −3.3
BC2 28.5 ± 10.9 14 7.5 ± 2.7 0.005 2.0; 12.9
PO 18.4 ± 6.4 19 −2.7 ± 2.5 0.285 −7.7; 2.2
Variation of testosterone was not sex or paO2 but SaO2 (P = 0.28) 
dependent.
Altitudes: PR, Pre expedition = 550 m; BC1, Base Camp 1 = 4.844 m; C2, 
Camp2 = 6022 m; BC2, Base Camp 2 (after acclimatization) = 4.844 m; C3, 
Camp3 = 7050 m; PO, Post expedition = 550 m.
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It is well known that hypobaric hypoxia leads to 
several cardiorespiratory and metabolic changes (12), 
which preserve sufficient performance at higher altitude. 
This is impressively demonstrated by the ability of 
humans to ascend to over 7000 m above sea level without 
additional oxygen. However, staying at this altitude is 
only possible for a brief period of time. The critical altitude 
for living permanently is usually about 5000 m, although 
this limit may vary depending on individual disposition 
and population group. The reasons for the limited ability 
of humans to live at a high altitude are not clear. It is 
known that a life-threatening form of altitude sickness 
can develop, which leads to physical degeneration and 
deterioration and is fatal. However, it is unclear what 
controls the metabolic changes at high altitude. This 
raises the question of whether these processes are also 
under endocrinological control.
Our study provides evidence for this hypothesis, as 
the adrenal axis is activated at high altitude, but can at 
least partially normalize at an altitude of about 5000 m. 
The strong activation of the adrenal axis as well as the 
thyroid axis, and inhibition of the gonadal axes at very 
high altitude suggest that adaptation might not be longer 
possible at this altitude, and thus, might contribute to the 
physical degradation. However, it needs to be stressed that 
the endocrine changes might only reflect the adaptation 
of the body without significantly affecting the physical 
status at high altitude. The dysregulation of the endocrine 
system at high altitude is only mild to moderate and the 
endocrine system might to some extent adapt to very 
high altitude.
Interestingly, the effects are not significantly different 
in men and women. We found similar effects in the 
adrenal and thyroid axes in both women and men. The 
gonadal axis could only be studied in men due to the 
Table 10 Pairwise comparisons of hormones shown in Tables 2, 3, 4, 5, 6, 7, 8 and 9 (P values, bold <0.05).
Cortisol 
female and 
male
Prolactin 
female and 
male 
TSH female 
and male
fT4 female 
and male
fT3 female 
and male FSH male LH male Testosterone male
Overall effect <0.001 0.054 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Ascent
 BC1 vs PR 0.001 0.016 0.240 <0.001 <0.001 0.159 <0.001 0.751
 C2 vs PR 0.971 0.953 0.594 <0.001 0.096 <0.001 0.046 0.271
 C3 vs PR 0.015 0.464 <0.001 <0.001 0.009 0.100 0.009 1.000
 C2 vs BC 0.001 0.994 1.000 1.000 0.967 0.393 1.000 0.387
 C3 vs BC1 <0.001 1.000 <0.001 0.009 1.000 0.999 1.000 0.997
 C3 vs C2 0.484 0.999 <0.001 0.076 0.864 1.000 1.000 0.018
Descent
 PO vs C3 0.008 0.823 <0.001 <0.001 0.122 0.046 0.077 1.000
 PO vs C2 0.887 1.000 0.008 <0.001 0.652 <0.001 0.275 0.104
 PO vs BC2 0.536 0.940 0.980 <0.001 1.000 0.746 0.985 <0.001
Acclimatization
 BC1 vs PR 0.001 0.016 0.240 <0.001 <0.001 0.159 <0.001 0.751
 BC2 vs PR 0.079 0.451 0.074 <0.001 0.161 0.936 0.492 0.006
 BC2 vs BC1 <0.001 0.999 0.017 0.009 <0.001 0.999 0.550 0.839
Long term effect
 PO vs PR 1.000 1.000 0.012 0.945 0.059 1.000 0.998 0.991
Data are adjusted for sex (Prolactin), SaO2 (fT3, Testosterone) and paO2 (TSH). Sidak adjustment for multiple comparisons was considered.
Figure 1
Cortisol concentration (nmol/L), representing a stress axis. Effect of 
altitude at 550 m before the expedition (PR), during ascent at 4.844 m 
(BC1), 6.022 m (C2) and 7.050 m altitude (C3), during descent at 4.822 m 
after acclimatization (BC2) and after the expedition at 550 m (P0). Boxes 
represent the 25th and 75th percentiles, and the bottom and top 
whiskers are defined by the 25th percentile minus 1.5 times the 
interquartile range (IQR) and the 75th percentile plus 1.5 times the IQR, 
respectively. Data points outside this range are plotted as individual 
points. Horizontal lines represent normal values. Statistical comparisons 
are shown in Tables 2 and 10.
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cycle-related fluctuations in female gonadotrophins, 
which is a limitation of the study. It can be assumed, 
however, that suppression of the gonadal axis also occurs 
in women at high altitude, since the female gonadal axis 
is very sensitive to stressors and reacts with a dysregulated 
hypothalamic–pituitary pulsatility (13). We had also 
analysed the pulsatility of the hormone secretion to 
identify very subtle changes of the endocrine regulation, 
which will be published in a different paper.
Previous studies have already investigated the effect 
of hypobaric hypoxia on the endocrine system.
Cortisol concentrations appear to increase with 
increasing altitude, according to previous studies. Woods 
et  al. showed a significant increase in resting cortisol 
concentrations at approximately 5000 m above sea 
level (8). Our study confirmed cortisol increase at high 
altitudes in both women and men. However, our study 
at 4844 m initially showed a cortisol decrease and a 
cortisol increase only at higher altitudes. Woods et al. also 
described lower cortisol levels below 5000 m (8). They 
found non-significantly lower concentrations at 4270 m 
compared to 5150 m. Significantly lower concentrations 
were noted when exercise (6-h trek) took place before the 
measurement.
Prolactin concentrations were previously found to first 
decrease in men at 5380 m, but then increase significantly 
if they stay at this altitude for several months (10). A 
significant increase in prolactin was also found in nine 
mountaineers in whom baseline prolactin levels were 
measured directly after climbing Mount Everest (5). Our 
study confirmed lower prolactin concentrations at 4844 m 
and elevated concentrations at 6022 m altitude. However, 
the increase was not significant.
Thyroid function dysregulations are not clear 
according to previous studies. Nepal et  al. compared 
thyroid function in indigenous people at 2800 and 
3750 m (9). fT4 was significantly elevated at 3750 m, but 
not fT3 and TSH. Basu et al. found significantly higher fT3 
and fT4 concentrations in soldiers after acclimatization 
at an altitude of about 6300 m (3). Hackney et al. found 
significantly lower TSH and fT3 concentrations in 15 
mountaineers who had climbed Denali in Alaska (6194 m), 
whereas fT4 concentrations remained unchanged (2). 
In our study, the most striking differences were found 
for fT4, which increased with altitude. Results were not 
clear for fT3 and TSH, but overall, the thyroid axis was 
activated. As the thyroid gland releases mainly T4, which 
is metabolized to T3, and as T4 has a much longer half-life 
than T3, it can be speculated that the altitude adaptations 
of thyroid function are easier to be detected using T4 
levels. TSH might also not be an ideal parameter for the 
detection of altitude-dependent functional changes as 
an increase in TSH may barely be detectable due to the 
negative feedback loop of T3 and T4 (14). Although a 
comparison of the studies is only possible to a limited 
extent and the data are somewhat heterogeneous, there 
appears to be an overall activation of the thyroid with 
increasing altitude, which is not detected at a pituitary 
level but in the thyroid gland.
Gonadal axes have previously poorly been studied. In 
the study by Benso et al., significantly reduced testosterone 
concentrations were found in eight mountaineers in 
the Base Camp at 5200 m directly after climbing Mount 
Everest (5); however, the interpretation of these results 
is limited due to the small number of test persons and 
excessive exertion. We found suppression of FSH and 
partly in LH with increasing altitude. Testosterone did 
not change very much but interestingly both LH and 
testosterone were reduced at 4800 m. As LH stimulation 
regulates the production of testosterone (15), it can be 
assumed that low testosterone concentrations are a result 
of suppressed LH.
Acclimatization and its effects have not yet been 
investigated in other studies with a suitable study design. 
Only the effect of several months’ stay at 5380 m (10) 
has been analysed so far. LH and total testosterone 
concentrations decreased significantly in 52 soldiers after 
6 months at this altitude. The hormone levels increased 
again within the next 6  months. Sperm concentration, 
motility and vitality were also significantly reduced after 
6 months at this altitude. Sperm concentration improved 
over the following 6  months, but not motility. After 
returning to lower altitudes, semen analysis normalized 
Figure 2
fT4 concentration (pmol/L), representing a thyroid axis. Legend: see Fig. 1. 
Statistical comparisons are shown in Tables 5 and 10.
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again. The decrease of semen parameters at high altitude 
was potentially relevant for fertility. There was a moderate 
asthenozoospermia at altitude, corresponding with 
andrological subfertility. Six months after starting the 
altitude exposure, the overall motility was on average 
about 35% and after 12 months about 28%. In our study, 
normalization of the stress axes in both sexes as well 
as the male gonadal axis after acclimatization was also 
demonstrated. We were able to show that normalization 
begins after just a few days.
All these study results raise the question of what causes 
these changes. Interestingly, the hormonal changes hardly 
correlated with parameters of oxygen transport such as 
O2 saturation and pO2 values, but only with altitude. 
Consequently, high-altitude hypoxia may not exclusively 
cause these changes, and other factors must also have 
an influence. The cold that occurs at high altitudes 
is probably not relevant or only of limited relevance 
because, due to good clothing, any relevant exposure to 
cold is mainly achieved via respiratory air. An effect of 
the increased physical burden at altitude due to hypobaric 
hypoxia is conceivable. 1, 8 demonstrated significantly 
higher cortisol levels or prolactin levels after physical 
exercise at an altitude of approximately 5000 m. The 
effect of disturbed sleep due to periodic breathing at high 
altitudes would also be conceivable in terms of the change 
in stress axes (16). Insomnia and shortened sleep leads to 
significantly higher cortisol levels, even at low altitudes 
(17, 18). However, sleep does not improve with increasing 
acclimatization (16), and disturbed sleep at high altitude 
cannot fully explain the endocrine changes, as these, in 
contrast to sleep, partially normalize at 4800 m. Because 
of this, it can be assumed that several height-dependent 
factors such as hypoxia, cold, physical stress, disturbed 
sleep, etc. have an influence and accumulate.
The question also arises if these endocrine changes 
might have a substantial effect on the health of humans 
living at high altitude for a long time. Insomnia leads to 
increased cortisol concentrations and to increased blood 
pressure and the risk for cardiovascular diseases (19). In 
line with this, patients with adverse cardiovascular events 
had higher median levels of cortisol (609.4 vs 594.4 pmol/
mL, P < 0.001) that those without (20). Clinical and 
subclinical hyperthyroidism is associated with different 
kinds of cardiovascular diseases (21). These effects might 
clinically be relevant as even a mild increase of blood 
pressure has an impact on mortality (22). The clinical 
consequences of high altitude on the gonadal axis has 
already been revealed by the above described studies on 
soldiers (10) which showed a clinically relevant reduction 
in sperm quality above about 5000 m.
Therefore, in our view, the hypothesis is acceptable 
that the endocrine system might play a role in the fact 
that human beings cannot live long term at very high 
altitude.
In summary, the investigations show an activation of 
the adrenal and thyroid axes and inhibition of the male 
reproductive endocrine axis, which partially normalize at 
least at altitude of about 5000 m. The endocrine changes 
found at higher altitude might contribute to the physical 
degradation and thereby to the incapability of humans to 
live permanently at very high altitude.
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